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Introduction
Low back pain is the single biggest cause of years lived with 
disability worldwide, and a major challenge to international 
health systems.1 In 2018, the Lancet Low Back Pain Series 
Working Group identified a global problem of mismanagement 
of low back pain.2–4 The group documented the phenomenon 
of unnecessary care in both high- and low-income settings, 
whereby patients receive health services, which are discordant 
with international guidelines.2–4 The articles summarized the 
strong evidence that unnecessary care, including complex pain 
medications, spinal imaging tests, spinal injections, hospital-
ization and surgical procedures, is hazardous for most patients 
with low back pain.2–4
Although we could not find systematic estimates for 
the worldwide prevalence of unnecessary care for low back 
pain, the CareTrack studies provide some indication of scale. 
Those studies estimated that 28% (95% confidence interval, 
CI: 19.7–38.6) of health care for low back pain in Australia 
(based on 164 patients receiving 6488 care processes)5 and 
32% (95% CI: 29.5–33.6) of health care for low back pain 
in the United States of America (based on 489 patients 
receiving 4950 care processes)6 was discordant with clinical 
guidelines. The figures are likely an underestimate because 
they did not include diagnostic imaging tests. The upward 
trend in unnecessary care for low back pain is even more 
concerning. One meta-analysis from 2018 found that simple 
imaging tests were requested in one quarter of back pain 
consultations (415 579 of 1 675 720 consultations) and the 
rates of complex imaging (e.g. magnetic resonance imaging) 
had increased over 21 years.7 There is no robust evidence of 
benefit for spinal fusion surgery compared with non-surgical 
care for people with low back pain associated with spinal 
degeneration.8 However, over the years 2004–2015, elective 
spinal fusion surgery in the United States increased by 62.3% 
(from 60.4 per 100 000 to 79.8 per 100 000), with hospital 
costs for this procedure exceeding 10 billion United States 
dollars (US$) in 2015.9 In 2014, 3–4% of the adult United 
States population (9.6 million to 11.5 million people of 318.6 
million) were prescribed long-term opioid drug therapy, in 
many cases because of chronic low back pain.10 The Lancet 
working group called on the World Health Organization to 
increase attention on the burden of low back pain and “the 
need to avoid excessively medical solutions.”4
The movement away from medicalized management of 
low back pain is reflected in recent clinical guidelines. All six 
of the major international clinical guidelines released since 
2016 prioritized non-medical approaches for patients with low 
back pain (Box 1).11–16 Primary-care clinicians following these 
guidelines would manage uncomplicated cases with advice, 
education and reassurance. For patients at risk of developing 
chronic pain and disability, clinicians would, depending on 
which guidelines they followed, consider offering treatments 
such as spinal manipulation, massage, acupuncture, yoga, 
mindfulness, psychological therapies or multidisciplinary 
rehabilitation. Most health systems are not well-equipped to 
support this approach.
Discontinuing unnecessary care of low back pain is ben-
eficial for patients. We argue that safer therapies should be 
offered, even though the evidence base for their effectiveness is 
not yet clear enough to achieve consistent endorsement across 
guidelines.11–16 In this paper we expand on the policy challenge 
of ensuring care for low back pain is concordant with guide-
lines and we outline potential solutions for health systems.
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Health-system challenges
Access to suitable therapies
While most people with low back pain 
will require little or no formal care, 
for those who do require extra help an 
immediate challenge is patients’ and 
clinicians’ lack of access to the recom-
mended therapies (Box 1). For example, 
a German survey found that general 
practitioners fundamentally agreed with 
the content of clinical guidelines for low 
back pain, but almost half had no access 
to the recommended multidisciplinary 
approach to pain management.17 A more 
recent qualitative study of general prac-
titioners in the United Kingdom of Great 
Britain and Norther Ireland concluded 
the same; one general practitioner 
viewed recommendations to provide a 
course of non-pharmacological care as 
“lovely pie-in-the-sky plans.”18
People living in rural and remote 
areas are often unable to access multidis-
ciplinary pain management because it is 
typically provided in tertiary health-care 
settings in cities. For example, a person 
with chronic low back pain living in 
Kununurra in rural Western Australia, 
which has a population of 5600, would 
have to travel 827 km to Darwin or 3040 
km to Perth to access their nearest multi-
disciplinary pain management service.19 
Patients may also have limited access 
to recommended physical and psycho-
logical therapies, and complementary 
therapies such as tai chi and yoga.
Br inging together  necessar y 
health services for people with com-
plex chronic conditions is a growing 
challenge for modern health systems. 
Australia’s chronic disease manage-
ment programme was designed to 
coordinate services across multiple 
providers. The programme, however, 
permits too few visits for proper de-
livery of effective coordinated care for 
chronic low back pain, since it only al-
lows for a total of five visits per annum 
per patient, shared across all allied 
health services and irrespective of the 
number of chronic conditions a patient 
has. For chronic low back pain, a pro-
gramme of primary care-based cogni-
tive behavioural therapy can consist of 
seven sessions20 and a programme of 
mindfulness-based stress reduction 
can be eight sessions.21 Exercise pro-
grammes could similarly exceed this 
cap; an effective yoga programme was 
shown to comprise 12 sessions.22 Some 
patients would also have to allocate 
one or more of their five sessions to 
manage comorbidities, such as diabe-
tes or obesity. The costs of providing 
this care are far lower than some of 
the unnecessary care options. For ex-
ample, the reimbursement offered by 
Medicare, Australia’s publicly funded 
health insurance scheme, for the five 
visits is only 311 Australian dollars 
(AU$), whereas spinal fusion surgery 
in a New South Wales public hospital 
is covered up to a cost of AU$ 53 700.23
Lack of time and training
The new guidelines require longer, 
more complex consultations. General 
practitioners cite time pressure and lack 
of confidence in new approaches to 
care as barriers to adherence to guide-
lines.24 Providing prognosis-specific care 
(Box 1) in a 5-minute consultation25 is 
next to impossible when treating a pa-
tient with severe pain, a poor prognosis 
or chronic low back pain with multiple 
comorbidities. One survey of 6588 con-
sultations for low back pain in Australia 
found that only around one fifth (21 of 
100) of general practitioners performed 
a complete history and physical exami-
nation.26
Most of the recommended second-
step treatment options require referral to 
clinicians with specific training. Some 
health systems, especially those in low- 
and middle-income countries, will not 
have the supply of clinicians to deliver 
these therapies at scale. For example, 
Nepal has only one physiotherapist per 
20 000 people, compared with 24 per 
20 000 in Australia.27
Furthermore, even when patients 
can access multidisciplinary pain man-
agement services, they may not receive 
care that is concordant with guidelines.28 
A patient living with chronic low back 
pain in West Virginia, a state with the 
highest opioid drug overdose rate in the 
United States, could receive a service 
that offers opioid medication, but not 
Box 1. Key messages from six international clinical guidelines for management of low back pain
• Adopt a stepped or stratified approach to care of low back pain, guided by the patient’s response to previous care or the results of risk prediction 
tools. Recommended by 4 out of 6 guidelines.11–14
• First step care for low back pain, which will be sufficient for many patients, is to provide advice to remain active, education on the benign 
nature of low back pain and reassurance about the absence of serious pathology. Recommended by all guidelines.11–16
• Second step options for acute low back pain include physical therapies (massage, spinal manipulation, heat-wrap therapy), psychological 
therapies (psychologically informed physiotherapy) or complementary therapies (acupuncturea). At least one recommended by all guidelines.11–16
• Second step options for chronic low back pain comprise physical therapies (exercise, massage, spinal manipulation), psychological therapies 
(cognitive behavioural therapy), complementary therapies (mindfulness-based stress reduction, yoga, acupuncture,a tai chi). Recommended 
by 4 out of 6 guidelines.11–13,15
• Third step in chronic low back pain care is multidisciplinary pain management (targets physical, psychological and social aspects of low back 
pain and involves a team of clinicians). Recommended by 5 out of 6 guidelines.11–15
• Care of low back pain care without medication is preferred. Recommended by all guidelines.11–16
• If pain medication is needed, begin with a nonsteroidal anti-inflammatory drug at the lowest effective dose for the shortest time. Recommended 
by all guidelines.11–16
• Avoid prescribing opioid drugs for low back pain where possible. Recommended by 3 out of 6 guidelines.11,14,16
• Do not offer injectable steroid drugs to patients with chronic non-specific low back pain. Recommended by 3 out of 6 guidelines.11,13,14
• Do not offer surgery for patients with non-specific low back pain outside of a randomized trial. Recommended by 3 out of 6 guidelines.11,13,14
a  Acupuncture was endorsed by the United States, Danish and Australian guidelines, but discouraged by United Kingdom and German guidelines. Belgian 
guidelines made no recommendation.
Notes: We analysed current clinical guidelines on low back pain care from six countries (United States of America, United Kingdom of Great Britain and Northern 
Ireland, Australia, Germany, Belgium and Denmark) released since 2016. Some specific details of recommendations differed between the guidelines.
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evidence-based care such as pain educa-
tion, coping strategies or rehabilitation 
services.29
Funding arrangements
Numerous companies and individuals 
profit from health care for low back pain. 
For example, Purdue Pharma L.P., mak-
ers of the opioid painkiller OxyContin® 
(oxycodone), has an estimated worth of 
US$ 13 billion. Oxycodone is the most 
used drug for chronic non-cancer pain 
in Australia.30 In the United Kingdom, 
prescriptions for opioids including 
oxycodone are increasing, despite evi-
dence of poor efficacy and substantial 
harm to patients.31 In 2013, prescription 
opioids were responsible for 44 000 drug 
overdose deaths in the United States.10 
A systematic review of randomized tri-
als found that opioids were of limited 
benefit in chronic low back pain, even 
in dangerously high doses,32 and a recent 
trial found opioids led to slightly worse 
pain outcomes than non-opioid medica-
tion for back pain and osteoarthritis.33 
The current international low back pain 
guidelines provide mixed messages re-
garding opioids. However, the Centers 
for Disease Control and Prevention 
guideline for prescribing opioid drugs 
for chronic pain are clear; extended-re-
lease opioids such as oxycodone should 
never be used for initial management of 
chronic non-cancer pain.34 
Fines for breaking the regulations 
around marketing of medicines to doc-
tors may not deter wealthy companies 
who want to increase their market 
share. Even a multi-million-dollar set-
tlement would be tiny for a major phar-
maceutical company that markets pain 
medicines. OxyContin® is estimated to 
have generated approximately US$ 35 
billion in revenue for its manufac-
turer.35 The largest settlement that we 
are aware of was around US$ 2.3 billion 
in 2009 paid by Pfizer Inc. to settle a 
misleading marketing case concern-
ing Lyrica® (pregabalin), a commonly 
prescribed drug for low back pain. The 
fine represented less than 5% of the 
company’s US$ 50 billion revenues that 
year. Regulators should keep in mind 
that such large companies can accept 
any fine as a cost of doing business in 
the area of pain relief.
Health-service funding arrange-
ments too can discourage the less-is-
more approach that suits most cases of 
uncomplicated, non-specific low back 
pain. Fee-for-service health systems, 
for example, tend to provide incen-
tives for activity and volume of care 
and hence inadvertently lead to more 
unnecessary care. A Cochrane review 
of systems of payment compared health 
service measures in two randomized 
controlled trials and two controlled 
before–after studies of 640 primary-
care physicians and 6400 patients. The 
review found that fee-for-service sys-
tems had higher numbers of contacts, 
visits to specialists and diagnostic and 
curative services compared with capi-
tation systems.36 Capitation systems, 
particularly those where clinicians 
receive a fixed salary to provide care 
for those enrolled in a given location, 
can reduce the number of services 
provided. However, capitation funding 
may also have undesirable effects, such 
as encouraging clinicians to provide 
the most time-efficient rather than the 
most effective care. Systems designed 
to solve these issues, such as pay-for-
performance systems and quality-based 
contingency payments, may not reward 
clinicians fairly for all the complexities 
involved in treating people with low 
back pain.
While knowledge of best practice 
for low back pain has evolved, our health 
systems and their funding mechanisms 
have not kept up. As a result, many 
health-care systems internationally con-
tinue to fund guideline-discordant care, 
such as opioid drugs, radiofrequency 
denervation and spinal fusion surgery 
(Box 1). These treatments were com-
mon practice before a robust system of 
assessment of best practice was in place. 
Current funding arrangements therefore 
present a challenging evidence–policy–
practice paradox. For example, Austra-
lian Medicare, and many private health 
insurers, do not fund guideline-concor-
dant self-care by patients, such as yoga 
and tai chi, and provide limited funding 
for supervised exercise programmes. 
There are two interrelated issues here. 
First, some of these alternative services 
lack a sufficiently robust evidence base 
that would allow them to pass an assess-
ment, which is rightly, a prerequisite for 
being added to the Australian Medicare 
fee-for-service schedule. Second, Medi-
care does not have a record of funding 
such alternative, non-medical interven-
tions, although this could change if the 
evidence base for these services were 
to improve and a submission was made 
for their inclusion in the schedule of 
payments.
Achieving guideline 
concordance
Some of the above challenges may ap-
pear insurmountable. However, we 
believe that with coordinated efforts 
targeting each level of the health system, 
change is possible. In Table 1 we provide 
suggestions for delivery arrangements, 
financial arrangements and governance 
of international health systems to better 
support guideline-concordant care for 
low back pain. Although most examples 
of initiatives in Table 1 are taken from 
high-income countries, we believe many 
could be trialled in low- and middle-
countries. Fig. 1 depicts a systems-level 
approach to achieving guideline con-
cordance.
Change ideas about back pain
Misconceptions about management of 
low back pain remain common. For 
example, around half of patients pre-
senting with low back pain (144 of 300) 
believed diagnostic imaging tests were 
necessary.47 Targeting misconceptions 
at the population level through mass-
media campaigns is an effective, but 
costly, approach. Campaigns such as the 
1997–1999 campaign in Victoria, Aus-
tralia, which encouraged people to “not 
take back pain lying down,” can change 
beliefs about low back pain and alter 
people’s behaviour, including the pro-
portion of patients returning to work.42 
The growth of social media should make 
similar campaigns easier and cheaper 
to implement. Targeting young people 
through health information messages 
on social media or other channels before 
unhelpful beliefs become entrenched 
is another worthwhile approach. The 
Informed Health Choices initiative in 
Uganda, which helped primary-school 
children and their parents detect false 
treatment claims, is evidence that these 
programmes can succeed.43 Whole-
population education initiatives, such 
as these could be expanded to include 
information about unnecessary diag-
nostic tests and to target condition-
specific health myths. However, those 
manufacturers or individuals who stand 
to gain financially from sales of certain 
therapies and who market opposing 
messages are a powerful force. Efforts 
to counteract such vested interests are 
likely to need sustained and coordinated 
support from the legislative, labour, 
health and government sectors (Fig. 1).
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Table 1. Health-system barriers to following guideline recommendations on care for low back pain, and potential policy solutions
Guideline recom-
mendation
Health-system 
barrier
Details Potential policy solutions (suitability for health systemsa)
Conduct a focused 
history and physical 
examination to 
determine patients’ 
risk of having a 
serious underlying 
cause of pain
Lack of time and 
training
Clinicians may lack adequate 
training in musculoskeletal 
assessment and 
management
Delivery arrangements 
• Increase training in history and examination procedures for low back 
pain and include the topics of unnecessary care and shared decision-
making in curricula for trainee clinicians (all health systems) 
• Provide easy access to training courses for clinicianson shared decision-
making for low back pain care (all health systems)37 
• Provide locally relevant care pathways for low back pain e.g. the 
National Low Back and Radicular Pain Pathway 2017 in the United 
Kingdom (fee-for-service systems, capitation systems)38 
• Build audit and feedback mechanisms on low back pain care, e.g. 
feedback on referral rates for diagnostic imaging tests (all health 
systems)39
Clinicians may be under time 
pressure during consultations 
for low back pain
Delivery arrangements 
• Enhance the role of nurse practitioners and physiotherapists in primary 
care as they may be less likely to prescribe unnecessary care for low 
back pain, e.g. imaging tests (all health systems)40 
• Assess the cost–effectiveness of using allied health staff who could 
provide equivalent low back pain care as physicians (all health 
systems)41 
• Encourage evaluations, embedded in routine care, of the cost–
effectiveness of any new model of low back pain care (all health 
systems) 
• Allow patients to self-refer to physical and psychological therapies care 
for low back pain (capitation systems) 
Financial arrangements 
• Provide reimbursement for clinicians needing extra time for patients 
with complex low back pain problems (fee-for-service systems, hybrid 
systems)
Screen patients 
using a prognostic 
model; arrange early 
referral to non-
pharmacological 
treatment for those 
at risk of a poor 
outcome
Vested interests 
and funding 
arrangements
Some clinicians, companies 
and professional associations 
market ineffective early 
interventions for low back 
pain
Governance 
• Impose fines for clinicians, companies and professional associations 
who make false claims about efficacy of services (all health systems) 
Prohibit direct-to-consumer advertising of non-evidence-based tests 
and treatments (all health systems)
Limited access to 
evidence-based 
information and 
health care
The prognosis of low back 
pain and the role of self-care 
is poorly understood by the 
public
Delivery arrangements 
•      Create mass-media campaigns informing the public about self-
management of low back pain, when to seek health care and how to 
identify false treatment claims (all health systems)42 
•      Create health literacy programmes about low back pain, e.g. school 
and podcast programmes targeting parents and their school-aged 
children (all health systems)43 
•      Encourage shared decision-making between clinician and patient 
on low back pain care, which can also increase informed decision-
making for other health conditions
Prioritize non-
pharmacological 
treatment for initial 
management
Limited access 
to coordinated, 
evidence-based 
health care
Physical, psychological and 
complementary therapies 
for low back pain may be 
unaffordable for patients
Delivery arrangements 
• Invest in existing eHealth programmes for low back pain care, e.g. 
clinician-guided, remotely delivered, cognitive behavioural therapy-
based pain management programmes (all health systems)44
Evidence-based non-
pharmacological treatment 
for low back pain is poorly 
integrated with general 
practitioner care.
Financial arrangements 
• Fund programmes of guideline-adherent non-pharmacological 
treatment for selected patients with low back pain, e.g. those at risk of 
chronic pain (all health systems) 
• Limit or remove expensive, non-evidence-based treatments for low 
back pain from funding schedules (all health systems) 
Set up bundled payment systems for low back pain care, e.g. 
comprehensive care for joint replacement programme which 
“coordinates care over the full continuum of services and eliminates 
spending that doesn't benefit patients” (all health systems45
Lack of time and 
training
Quality cognitive-behavioural 
therapy for low back pain is 
hampered by shortages of 
health workers, e.g. clinical 
psychologists
Governance 
• Provide government subsidies for university training positions on for 
low back pain care in needed health professions (all health systems)
(continues. . .)
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Guideline recom-
mendation
Health-system 
barrier
Details Potential policy solutions (suitability for health systemsa)
If medication is 
needed, begin with 
simple analgesics 
such as nonsteroidal 
anti-inflammatory 
drugs
Vested interests 
and funding 
arrangements
Complex medicines for low 
back pain that lack evidence 
of lack of efficacy are 
aggressively marketed
Governance 
• Impose fines for pharmaceutical companies who make false claims 
about efficacy and safety of products (all health systems) 
• Require post-marketing evaluation to measure impact of use 
of medicine outside of the indications where efficacy has been 
demonstrated (all health systems)
Medicines and procedures 
that are ineffective for low 
back pain are funded by 
public or private insurance 
schemes
Financial arrangements 
• Tighten or restrict indications for financial coverage of low back pain 
care, e.g. only fund treatment when there is evidence for clear benefit or 
in the context of a randomized trial to gather evidence (fee-for-service 
systems, capitation systems) 
Governance 
• Ensure agreements between all stakeholders involved in funding, 
provision and evaluation of therapies for low back pain and that 
evaluations are only done in the context of a clinical trial (all health 
systems) 
• All clinical trials for low back pain treatment should pre-specify what 
outcomes constitute positive and negative results (all health systems) 
• Require regular health technology assessments and reassessments of 
health services for low back pain46 (all health systems)
Over-the-counter medicines 
that are either ineffective 
(paracetamol) or untested 
(codeine combinations) in 
low back pain are cheap 
and easy to access from 
community pharmacies
Governance 
• Change opioid drugs, e.g. codeine combinations, from over-the-
counter to prescription-only medicine (all health systems)
Avoid the following: 
(i) prescribing opioid 
drugs; 
(ii) referral for routine 
diagnostic imaging 
tests; 
(iii) prescribing 
steroid injections for 
patients with chronic 
low back pain; and 
(iv) referral for 
surgery for patients 
with chronic non-
specific low back 
pain, outside of a 
randomized trial
Vested interests 
and funding 
arrangements
Providers (physicians, 
radiologists and surgeons), 
device manufacturers and 
pharmaceutical companies 
profit from low back pain 
care
Governance 
• Compulsory review of all new drugs, equipment and practices for 
low back pain care, e.g. standard health technology assessment and 
reassessment (all health systems)46
Limited access 
to coordinated, 
evidence-based 
health care
Patients, clinicians and the 
public believe that that 
opioid drugs, imaging tests 
and surgery are necessary 
care for low back pain
Delivery arrangements 
• Create mass-media campaigns to warn health providers and the public 
about unnecessary care for low back pain (all health systems)
Vested interests 
and funding 
arrangements
Public or private insurance 
schemes reimburse patients 
for low back pain care that 
is not concordant with 
guidelines, e.g. opioid drugs, 
imaging tests and surgery
Financial arrangements 
• Tighten or remove indications for health-care coverage, e.g. only fund 
treatments for low back pain where there is evidence for clear benefit 
or, if there is absence of evidence, in the context of a randomized trial 
(fee-for-service systems, capitation systems)
a  We indicate which types of health-care funding systems are most suitable for interventions: all health systems (including low- and middle-income countries); fee-
for-service systems (e.g. Australia); capitation systems (e.g. United Kingdom of Great Britain and Northern Ireland); hybrid systems, i.e. combination of fee-for-service 
and capitation (e.g. United Sates of America).
(. . .continued)
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Clinicians require more training 
and educational support from health 
systems if they are to use new ap-
proaches to back pain care. Educational 
materials48 and workshops49 can improve 
care quality. Key topics could include 
emphasizing the need for a history and 
physical examination in patients with 
low back pain and building skills in ad-
dressing patient concerns and requests 
for unnecessary care, such as imaging 
tests in the absence of clinical features 
of serious pathology. Decision-making 
shared with the patient can reduce un-
necessary tests in other non-serious pain 
conditions,50 although it remains unclear 
exactly how health systems can improve 
uptake of shared decision-making be-
tween clinicians and patient.51
A more immediate solution would 
be to borrow behavioural approaches 
that have shown promise in other areas 
of health care. Behavioural interven-
tions, for example, can counteract 
cognitive biases and improve clinical 
decision-making. Something as simple 
as a letter to clinicians, noting their 
poor prescribing habits in comparison 
with their peers, can have a substantial 
impact. A recent randomized trial by 
the Australian health department in-
volved sending peer-comparison letters 
to 6649 high-prescribers of antibiotics. 
The outcome was a reduction in their 
prescriptions for inappropriate anti-
biotics from 109.3 to 95.8 scripts per 
1000 consultations (12.3% reduction 
over 6 months).52 A similar trial found 
sending peer comparison letters to 
5055 high-prescribers of antipsychotic 
drugs reduced prescriptions from 2864 
to 2456 patient days on quetiapine per 
prescriber (adjusted difference, −319 
days of 2864; 11.1% fewer days over 
9 months).53
Another strategy to increase deliv-
ery of guideline-concordant care could 
be redesigning electronic health records. 
An observational study conducted in 
two emergency departments in Penn-
sylvania in the United States found that 
making 10 tablets the default option for 
prescriptions in the system was associat-
ed with a 22.8% increase in prescriptions 
for 10 tablets (from 20.6% to 43.3% of 
3264 prescriptions) and a 6.7% decrease 
in prescriptions for 20 tablets (from 
22.8% to 16.1% of 3264 prescriptions) 
over 4 weeks.54 Electronic health record 
systems are increasingly being used to 
collect clinical data, auto-populate risk 
prediction tools with relevant clinical 
and demographic data, and default to 
the most appropriate strategy for that 
person’s risk profile. While trials of such 
innovations are needed to determine 
their optimal design and assess their 
acceptability and usefulness, such ap-
proaches have the advantage that they 
could be implemented on a large scale 
and at relatively low cost.
Incentivize high-value care
Aligning funding models with best-
practice care for low back pain could be 
difficult. As mentioned above, funding 
schedules already cover many non-
evidence based items which remain 
popular with clinicians and patients and 
are difficult to remove funding from.55 
One example of success was the removal 
of the vertebroplasty procedure from the 
Australian Medicare funding schedule. 
A key factor in this achievement, how-
ever, was that vertebroplasty had only 
interim funding status that was contin-
gent on trial results. When the trials did 
not show positive outcomes, funding for 
the therapy was denied, albeit with the 
controversy that comes with restricting 
or removing access. Funding is unlikely 
to shift from established care practices 
unless there is clear evidence for the 
superior safety, effectiveness and cost–ef-
fectiveness of the alternatives. Funding 
decisions are complex and rarely are 
such decisions influenced solely by evi-
dence. Lobbying from vested interests, 
media coverage and communication 
around funding decisions, patient and 
clinician resistance to changes, as well 
as the current political climate, and the 
alignment of these factors with public 
opinion, also play an influential role 
(Fig. 1). The public needs to have a bet-
ter understanding of the shortcomings 
of some types of established medical 
care. Many patients may already have 
such understanding (Box 2) and, in 
fact, patients could help drive changes 
to the system by lobbying for care that 
is evidence-based (see Local context, 
Fig. 1). In Oregon in the United States, 
patients, clinicians and policy-makers 
recently designed a new way to pay 
for appropriate care for low back pain. 
Oregon will be the first American state 
to reallocate Medicaid funds away from 
ineffective and potential harmful thera-
pies for low back pain, such as long-term 
opioids, to evidence-based, non-medical 
treatments.56
The optimal way to pay clinicians 
who treat low back pain remains un-
clear. Modest financial incentives for 
providing guideline-concordant care are 
unlikely to change practice.57 There is, 
however, potential for episode-of-care 
reimbursement or risk-adjusted capita-
tion payment models to provide incen-
tives for complying with guidelines. 
Simulation models using data from 969 
medical practices in the United States 
found that replacing fee-for-service with 
fixed monthly capitation payments, to 
cover all costs associated with provid-
ing primary care, could encourage the 
delivery of more care outside of consul-
tations without financial losses from the 
government health-care budget.58
Regulate vested interests
Governments will have a key role to 
play in supporting new approaches to 
managing low back pain. Some shifts 
have already begun. The Australian Gov-
ernment scheduled codeine products 
as prescription-only drugs in February 
2018. This change is likely to reduce the 
overuse of these medicines, although the 
broader consequences of such policies 
remain unclear. In 2010, in the United 
States, after government reduced access 
to a formulation of OxyContin® that was 
easily abused, use of the drug dropped 
substantially (from 35.6% to 12.8% of 
2566 patients), but many patients who 
abused both formulations (66 of 100) 
simply switched to using heroin.59 Any 
attempt to restrict public access to opi-
oids should therefore be accompanied 
by adequate access to addiction services, 
social programmes and evidence-based 
non-pharmacological alternatives, as 
well as programmes to accurately moni-
tor use of opioids.
Changes to governance arrange-
ments will have to occur not just in 
health systems, but also in the complex 
framework in which health systems 
operate. Encouraging a shift away from 
unnecessary medical care requires sup-
port from governments, workplaces, 
legislative systems, consumers and 
professional bodies (Fig. 1).
Conclusion
Delivery of guideline-concordant care 
for low back pain requires system-wide 
changes. Strong governance at each 
level of the health system will be key 
to redefining how society views and 
manages low back pain. Health systems 
should prioritize policies that: empower 
clinicians and consumers to make well-
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Fig. 1. Health system levers to increase concordance with guidelines for care of low back pain
Patient receives 
guideline-based care
Governance
• Impose fines for false claims 
about product efficacy
• Encourage post-marketing 
evaluation of therapies
• Commission high-quality 
trials of therapies 
• End direct-to-consumer 
advertising of therapies
• Regulate companies with 
financial interests in 
therapies that are not 
guideline-concordant
• Conduct health technology 
assessment and 
reassessment
• Subsidize university places 
for in-demand health 
professionals
Funding arrangements
• Restrict indications for 
publicly funded care that is 
not guideline-concordant
• Fund programmes of 
guideline-based care 
for selected patients
• Incentivize quality, 
not quantity of care
• Re-orient the 
workforce to support 
guideline-concordant care
Delivery arrangements
• Improve clinicians’ training 
in appropriate care
• Inform the public about 
appropriate care
• Optimize evidence based 
front-line care
• Promote shared 
decision-making between 
clinician and patient
• Invest in cost-effective 
remotely delivered  ‘eHealth’ 
interventions
Local context 
Legal system Societal context Patient or public demand Political system Workplace system
Notes: The boxes are arranged, from left to right, in order of health policy level: governance refers to the highest policy level, followed by funding arrangements, 
then delivery arrangements. The arrows indicate that policies at one level can have downstream effects on other levels, ultimately influencing the likelihood that 
a patient receives guideline-based care. Some policies in this example will be easier to implement than others, depending on local context. Local context factors 
that are external to, but interact with, components of the health system, are likely to influence delivery of guideline-concordant care. 
Box 2. Examples of patient perspectives on management of chronic low back pain
Example 1
A patient with many years of chronic arthritis and back pain:
“What I want and have always wanted is to stay positive, keep the pain at a comfortable level, and stay independent. Big things that have helped 
me were a good rapport with my boss so I could work some days from home and have my desk and seat adapted….joining in with groups for 
regular exercise to keep me mobile (aqua aerobics for me!)…and feeling valued so I am seen as ‘me the worker or the volunteer’ and not ‘me as 
the person with the pain’.
Medical treatments, including strong painkillers, have certainly helped at particular times of my life. But I really wish that, years ago, when all the 
pain began, there had been messages like the ones in the guidelines now. I wish there had been someone suggesting things to try for myself 
and to be positive about staying active and learning ways of getting on with life despite the pain. Doctors shouldn’t be nervous about suggesting 
people try things like heat packs and exercise first before reaching for tablets or injections – it could be a real ‘lightbulb’ moment for the patient.
But I know just how difficult this is when doctors are so busy. I was proud to be involved in a scheme for patients to help other patients with advice 
about simple things like public transport when they were anxious about even trying it. I have gained such a lot from doing things for myself, and 
I like the idea of recommending and funding more help and support for other patients with back pain to learn how to do the same – and shifting 
from care being all about drugs and injections.”
Example 2
A former nurse who has had back pain for many years:
“I started with back pain when I was 30 [years old] and it became so bad when I was nursing that I went from paracetamol to codeine to morphine 
patches. I had read about the patches and insisted my doctor prescribed them even though he was not too keen. The patches did help the pain, 
but they made me feel worse and I gave up after a few months. I had to give up nursing because I couldn’t move patients and that upset me. And 
then I decided to tackle the back pain myself.
A physiotherapist gave me some exercise sheets – 15 years later I still have them and use them. I lost weight, I stopped heavy lifting. The pain is 
there but I can cope with it. Not only did I get my pain under control, I felt so much better in myself. I now gauge my activity by what I feel my 
body can manage – [it’s] so much better than popping pills even though I still take the occasional painkiller to help when the back pain is bad. I 
get help from talking with other people. That’s what people need when they get back pain – someone who has time to listen, understands the 
pain, and helps them to find ways to stay active and engaged by way of exercise and work, rather than just giving a prescription for painkillers.”
Source: The two patients are members of the patient and public involvement panel at Keele University’s Institute of Primary and Health Care Sciences, England. 
They provided these thoughts after reading a draft of the paper before submission.
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informed choices; encourage clinicians 
to deliver the right care to those who 
need it most; provide financial support 
to evidence-based non-pharmacological 
treatment; and regulate the influence of 
those with vested interests in the current 
situation. Small adjustments to health 
policy will not work in isolation. Work-
place systems, legal frameworks, person-
al beliefs, politics and the overall societal 
context in which we experience health, 
will also need to change. Addressing 
system-level barriers to guideline-based 
care could be cost-neutral; every year 
health systems waste billions of dollars 
on unnecessary tests and treatments 
for low back pain. Although disinvest-
ment is difficult, redistributing funds to 
support guideline-concordant care is a 
promising way forward. Because cur-
rent approaches to treatment often lack 
formal evidence, we strongly encourage 
careful evaluation of any new approach 
to funding or service delivery. ■
Acknowledgements
RB is also affiliated with Cabrini Insti-
tute, Malvern, Australia.
Competing interests: Between November 
2017 and February 2018 AT provided 
paid consultancy to a health insurance 
company regarding evidence-based mod-
els of physiotherapy care.
摘要
腰痛护理：卫生系统能提供些什么？
腰痛是与全球残疾人士相伴数年的一项主要病因。
2018 年，某国际工作小组呼吁世卫组织加强对腰痛负
担的关注，并尽力避免过度医疗。事实上，主要国际
临床指南现已认可腰痛患者只需极少治疗或无需正式
治疗。使用止痛药、注射类固醇和进行腰椎手术并非
值得鼓励的推荐疗法，相应地，患者应改善生理和心
理状态。但许多卫生系统并非为支持此疗法设计。在
本文中，我们讨论了符合指南的腰痛护理为何需要进
行系统性变革，并详述了卫生系统中腰痛护理的关键
挑战，包括制药公司与其它公司的经济利益 ；过时的
医疗保险偿付系统更倾向于让患者接受医疗服务而非
自我管理 ；以及医生与公众对腰背痛护理的医疗传统
和信仰早已根深蒂固。我们为因腰痛护理无效而面临
沉重负担的卫生系统提供了一些国际案例，包含颇有
前景的解决方案、政策和实践。我们建议施行成本适
中、有广泛影响的政策，将不必要的护理资源转换成
符合指南的腰痛护理。然而，卫生政策方面的微小调
整无法单独起作用，这同时也需要工作场所制度、法
律框架、个人信仰、政治以及我们所期望的卫生系统
整体社会环境的相应改变。
Résumé
Prise en charge des lombalgies: les systèmes de santé peuvent-ils suivre?
Les lombalgies sont la principale cause d'années de vie vécues avec une 
incapacité dans le monde. En 2018, un groupe de travail international 
a invité l'Organisation mondiale de la Santé à attirer l'attention 
sur la charge que représentent les lombalgies et sur la nécessité 
d'éviter le recours excessif aux solutions médicales. En effet, selon les 
dernières recommandations cliniques internationales, de nombreux 
cas de lombalgie ne nécessitent pas ou peu de traitement formel. 
Lorsqu'un traitement est requis, il est recommandé de limiter la prise 
d'analgésiques, les injections de stéroïdes et la chirurgie rachidienne, et 
d'encourager plutôt les thérapeutiques physiques et psychologiques. 
Très souvent, les systèmes de santé ne sont pas conçus pour appliquer 
cette approche. Dans cet article, nous abordons les raisons pour 
lesquelles un changement des systèmes s'impose si l'on veut prendre 
en charge les lombalgies suivant les recommandations. Nous détaillons 
les principales difficultés de la prise en charge des lombalgies dans le 
cadre des systèmes de santé. Il s'agit notamment des intérêts financiers 
صخلم
؟اهمدقت نأ ةيحصلا مظنلل نكمي له :رهظلا لفسأ ملاآ ةياعر
 ءاضقل  لماعلا  ىوتسم  لىع  سييئرلا  ببسلا  يه  رهظلا  لفسأ  ملاآ
 ةعوممج تبلاط ،2018 ماع في .ةقاعلإا لظ في ةايلحا نم تاونس
 ملاآ  ءابعأب  مماتهلاا  ةدايزب  ةيلماعلا  ةحصلا  ةمظنم  ةيلود  لمع
 .طرفم  لكشب  ةيبطلا  ليلاحلما  بنتج  لىإ  ةجالحاو  ،رهظلا  لفسأ
 ةيلالحا  ةيسيئرلا  ةيلودلا  ةيريسرلا  ةيهيجوتلا  ئدابلما  نأ  عقاولاو
 لفسأ  ملاآ  نم  نوناعي  نيذلا  صاخشلأا  نم  ديدعلا  نأ  كردت
 نوجاتيح  لا  وأ  ،يمسرلا  جلاعلا  نم  ليلقلا  لىإ  نوجاتيح  رهظلا
 وه  هب  صىولما  بولسلأا  نإف  ،اًبولطم  جلاعلا  نوكي  امدنع  .هيلإ
 ةحارجو  ،ديويرتسلا  نقحو  ،لملأل  ءاود  مادختسا  نع  داعتبلاا
 ةيندبلا  تاجلاعلل  جيوترلا  متي  كلذ  نم  لادبو  .يرقفلا  دومعلا
 معدل ةممصم تسيل ةيحصلا مظنلا  نم ديدعلا  نأ لاإ .ةيسفنلاو
 لفسأ ملاآ ةياعر بلطتت اذالم ثحبلا اذه في شقانن .بولسلأا اذه
 نحن .لماكلاب ماظنلا في تايريغت ،تاداشرلإا عم ةقفاوتلما رهظلا
 رهظلا  لفسأ  ملاآب  ةيانعلل  ةيسيئرلا  تايدحتلا  ليصفتلاب  لوانتن
 ةيودلأا  تاكشرل  ةيلالما  حلاصلما  لمشت  يهو  .ةيحصلا  مظنلا  في
 لضفت  يتلا  ةميدقلا  عفدلا  ةمظنأ  لثم  ؛تاكشرلا  نم  اهيرغو
 تادقتعلماو ديلاقتلاو ؛ضىرملل ةيتاذلا  ةرادلإا لىع ةيبطلا  ةياعرلا
 نحن .ةماعلاو ءابطلأا ينب رهظلا ملاآ ةياعر نأشب ةخسارلا ةيبطلا
 مظنلل ةدعاولا تاسرمالماو تاسايسلاو لولحلل ةيلود ةلثمأ يطعن
 ملالآ  ةلاعفلا  يرغ  ةياعرلا  نم  اديازتم  ًائبع  هجاوت  يتلا  ةيحصلا
 دراولما ليوتح للاخ نم - اهنكمي تاسايس حترقن ماك .رهظلا لفسأ
 ةيهيجوتلا ئدابلما عم ةقفاوتلما ةياعرلا لىإ ةيروضرلا يرغ ةياعرلا نم
 يرثأت الهو ةفلكتلا  ثيح نم ةديامح نوكت نأ -  رهظلا لفسأ ملالآ
 ةسايسلا  في  ةطيسبلا  طبضلا  تايلمع  نأ  لاإ  .راشتنلاا  عساو
 نم لك يريغتلل  ًاضيأ  جاتحيس ثيح .اهدرفمب  لمعت  نل  ةيحصلا
 ،ةيصخشلا تادقتعلماو ،ةينوناقلا لمعلا رطأو ،لمعلا ناكم ةمظنأ
.ةحصلا في ههجاون يذلا ماعلا يعمتجلما عباطلاو ،تاسايسلاو
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des laboratoires pharmaceutiques, entre autres; des systèmes de 
paiement obsolètes qui privilégient la prise en charge médicale à 
l'autogestion par les patients; et de croyances et traditions médicales 
profondément ancrées parmi les médecins et la population. Nous 
donnons des exemples internationaux de solutions, de politiques et de 
pratiques prometteuses pour les systèmes de santé confrontés de plus 
en plus souvent à une prise en charge inefficace des lombalgies. Nous 
suggérons des politiques qui, sans incidence sur les coûts, en transférant 
les ressources allouées aux soins inutiles vers des soins conformes aux 
recommandations, pourraient avoir un impact considérable. De petits 
ajustements des politiques de santé ne suffiront cependant pas. Les 
systèmes des milieux professionnels, les cadres juridiques, les croyances 
personnelles, les politiques et le contexte sociétal global dans lequel 
s'inscrit la santé devront également changer.
Резюме
Медицинская помощь при боли в поясничной области: насколько эффективны системы 
здравоохранения
Боль в поясничной области является основной причиной 
многолетней инвалидности во всем мире. В 2018 году 
международная рабочая группа призвала Всемирную 
организацию здравоохранения уделять больше внимания 
бремени боли в поясничной области и необходимости 
исключения чрезмерного медицинского вмешательства. В связи 
с этим основные международные клинические рекомендации на 
настоящий момент признают, что большинству пациентов с болями 
в поясничной области практически не требуется формального 
лечения. В случае если лечение необходимо, рекомендуемый 
подход не советует использовать обезболивающие препараты, 
инъекции стероидов и операции на позвоночнике, предлагая 
вместо этого активно использовать физическую терапию и 
психотерапию. Многие системы здравоохранения не в состоянии 
поддерживать данный подход. В этой статье авторы обсуждают 
причины, по которым рекомендуемая медицинская помощь 
при боли в поясничной области требует реформирования 
всей системы здравоохранения. Авторы подробно описывают 
основные проблемы лечения боли в поясничной области в 
рамках различных систем здравоохранения. Среди них следует 
отметить финансовые интересы фармацевтических и других 
компаний; устаревшие платежные системы, делающие упор 
на оказание медицинской помощи вместо обучения пациента 
методам самопомощи; глубоко укоренившиеся традиции и 
убеждения у врачей и широкой общественности относительно 
медицинской помощи при боли в поясничной области. Авторы 
приводят примеры возможных международных решений, а также 
политики и практические подходы для систем здравоохранения, 
сталкивающихся с растущим бременем неэффективной помощи 
при боли в поясничной области. В статье предлагаются процедуры 
и методики, которые могут не требовать дополнительных 
расходов и иметь широкомасштабное воздействие благодаря 
переключению ресурсов с оказания ненужной медицинской 
помощи на согласующуюся с рекомендациями помощь при 
боли в поясничной области. Однако небольшие корректировки 
политики в области здравоохранения не будут эффективными, 
если они будут проводиться изолированно друг от друга. 
Необходимо также преобразование систем на рабочих местах, 
правовых основ, личных убеждений, политик и общественного 
контекста, связанных со здравоохранением.
Resumen
Atención del dolor lumbar: ¿los sistemas de salud son eficaces?
El dolor lumbar es la causa principal de vivir con discapacidad durante 
años en todo el mundo. En 2018, un grupo de trabajo internacional 
pidió a la Organización Mundial de la Salud que prestara más atención 
a la carga del dolor lumbar y a la necesidad de evitar soluciones 
excesivamente médicas. De hecho, las principales directrices clínicas 
internacionales reconocen ahora que muchas personas con dolor 
lumbar requieren poco o ningún tratamiento formal. Cuando se 
requiere tratamiento, el enfoque recomendado es desalentar el uso de 
analgésicos, inyecciones de esteroides y cirugía de la columna vertebral 
y, en su lugar, promover las terapias físicas y psicológicas. Muchos 
sistemas de salud no están diseñados para apoyar este enfoque. En este 
documento, se expone por qué el cuidado del dolor lumbar de acuerdo 
con las directrices requiere cambios en todo el sistema. Se detallan los 
retos clave de la atención del dolor lumbar en los sistemas de salud. 
Estos incluyen los intereses financieros de las compañías farmacéuticas 
y de otro tipo, los sistemas de pago obsoletos que favorecen la atención 
médica por encima del autocuidado de los pacientes, así como las 
tradiciones y las creencias médicas profundamente arraigadas sobre la 
atención del dolor de espalda entre los médicos y el público general. Se 
presentan ejemplos internacionales de soluciones prometedoras y de 
políticas y prácticas para los sistemas de salud que se enfrentan a una 
carga cada vez mayor de la atención ineficaz para el dolor lumbar. Se 
sugieren políticas que, al desplazar los recursos de la atención innecesaria 
a la atención acorde con las directrices para el dolor lumbar, podrían 
ser neutras en cuanto a costes y tener un impacto generalizado. Sin 
embargo, los pequeños ajustes en la política sanitaria no funcionarán 
de forma aislada. Los sistemas del lugar de trabajo, los marcos jurídicos, 
las creencias personales, la política y el contexto social general en el que 
vivimos la salud también tendrán que cambiar.
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